The number of individual cases identified in EudraVigilance for COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19) is 332,433 (up to 17/07/2021)
Number of individual cases by Age Group
Pivot Table Prompts
Sections
Age Group
Cases
%
Not Specified
24,983
7.5%
0-1 Month
223
0.1%
2 Months - 2 Years
339
0.1%
3-11 Years
268
0.1%
12-17 Years
203
0.1%
18-64 Years
259,377
78.0%
65-85 Years
44,551
13.4%
More than 85 Years
2,489
0.7%
Total
332,433
100.0%
saw.dll?DocPart&StateID=1121750820
Number of individual cases by Sex
Pivot Table Prompts
Sections
Sex
Cases
%
Female
239,683
72.1%
Male
84,411
25.4%
Not Specified
8,339
2.5%
Total
332,433
100.0%
saw.dll?DocPart&StateID=1121750821
Number of individual cases by Geographic Origin (EEA/Non-EEA)
Pivot Table Prompts
Sections
Occurrence Country EEA/Non EEA
Cases
%
European Economic Area
163,094
49.1%
Non European Economic Area
169,339
50.9%
Not Specified
0
Total
332,433
100.0%
saw.dll?DocPart&StateID=1121750822
Number of individual cases by Reporter Group
Pivot Table Prompts
Sections
Reporter Group
Cases
%
Healthcare Professional
81,718
24.6%
Non Healthcare Professional
250,715
75.4%
Not Specified
0
Total
332,433
100.0%
saw.dll?DocPart&StateID=1121750823
For the interpretation of the results, please refer to the key considerations at www.adrreports.eu
Move a group to the "Groups with Permission" area to allow members to use this Saved Customization. Check the box next to a group to make this Saved Customization its default.